Home Industries Market Insights About Us Publisher Contact us

Global Oncology Companion Diagnostic Market Research Report 2021 - Future Opportunities, Latest Trends, In-depth Analysis, and Forecast To 2028

ReportID: 563597

|

Published Date: September 2021

|

No. of Pages: 250

|

Categories: IT & Telecommunication

|

Formate :

The A2Z Market Research report on “Global Oncology Companion Diagnostic Market Report 2021 – Future Opportunities, Latest Trends, In-depth Analysis, and Forecast To 2028” offers strategic visions into the global Oncology Companion Diagnostic market along with the market size (Volume – Million Units and Revenue – US$ Billion) and estimates for the duration 2021 to 2028. The said research study covers in-depth analysis of multiple market segments based on type, application, and studies different topographies. The report is also inclusive of competitive profiling of the leading Oncology Companion Diagnostic product vendors, and their latest developments.

This report has been segmented by type, by application and by geography and also includes the market size and forecast for all these segments. Compounded annual growth rates for all segments have also been provided for 2021 to 2028. The study highlights current market trends for Oncology Companion Diagnostic and also provides the future trends that will impact the demand. Year-on-year growth rates are also provided for each segment covered in the global Oncology Companion Diagnostic market report. The report also analyzes the market from production perspective and includes raw material cost analysis, technology cost analysis, labor cost analysis, and cost overview for the Oncology Companion Diagnostic market.

Market Segmentation by Type:
Polymerase Chain Reaction (PCR)
Next-Generation Sequencing (NGS)
Immunohistochemistry (IHC)
In situ hybridization (ISH)/Fluorescence in situ hybridization (FISH)
Others

Market Segmentation by Application:
Hospital
Pathology/Diagnostic Laboratory
Academic Medical Center

By geography, the market has been segmented into North America, South America, Asia, Europe, Africa and Others. Under North America, the report covers the United States, and Canada; whereas Asia includes China, Japan, India, Korea, and Southeast Asia. The key countries covered under Europe include Germany, United Kingdom, France, and Russia whereas ‘Others’ is comprised of Middle East and GCC countries. The present market size and forecast till 2028 for all the regions and sub-regions have also been provided in the report.

This report covers the Major Players’ data, including: shipment, revenue, gross profit, interview record, business distribution etc., these data help the consumer know about the competitors better. It also includes competitive scenario in the market and offers insights into the manufacturer share from 2015 to 2018 both in terms of shipment and revenue for all major players identified in the global Oncology Companion Diagnostic market. Other key parameters include plant location, technology source, downstream industry, and contact information among others.

Some of the important players in Oncology Companion Diagnostic market are:
Agilent Technologies, Inc.
Illumina, Inc.
Qiagen N.V.
Thermo Fisher Scientific Inc.
F. Hoffmann-La Roche Ltd.
ARUP Laboratories
Abbott
Myriad Genetics, Inc.
bioMérieux SA
Invivoscribe, Inc.

Request For TOC

To receive a sample copy of this report, please complete the form below

Kindly share your specific requirement (if any)

Request For List Of Tables

To receive a sample copy of this report, please complete the form below

Kindly share your specific requirement (if any)

Price

Single User

US$3400

Multi User

US$5100

Corporate User

US$5100

Excel Datapack

US$2000

Download Sample Report

Kindly share your specific requirement (if any)
970580f357b66011f3ad9bfd8fd4652a.png

Global Oncology Companion Diagnostic Market Research Report 2021 - Future Opportunities, Latest Trends, In-depth Analysis, and Forecast To 2028